Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Lupin Biologics Limited, is an unlisted public company incorporated on 28 January, 2021. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 15.00 lac.
The current status of Lupin Biologics Limited is - Active.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Vinita Deshbandhu Gupta | 00058631 | 4 years |
Director | Nilesh Deshbandhu Gupta | 01734642 | 4 years |
Director | Ramesh Swaminathan | 01833346 | 4 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
ZYMA PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
SYNCHEM PROPERTIES PRIVATE LIMITED |
Active
|
11.0 Cr | 2 | Maharashtra |
LUPIN INVESTMENTS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
LUPIN LIMITED |
Active
|
91.2 Cr | 3 | Maharashtra |
ZYMA LABORATORIES LIMITED |
Amalgamated
|
1.4 Cr | 1 | Maharashtra |
ORGO MERCANTILE TRADERS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
D. B. ESTATE TRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
RAHAS MULTITRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
BS MERC PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
LUPIN INTERNATIONAL PRIVATE LIMITED |
Amalgamated
|
5.0 L | 1 | Maharashtra |
RAHAS INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 1 | Maharashtra |
NOVODIGM LIMITED |
Amalgamated
|
2.4 Cr | 2 | Gujarat |
NOVEL CLINICAL RESEARCH (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
ELEMENT119 LEASING AND FINANCE PRIVATE LIMITED |
Dissolved
|
2.0 Cr | 1 | Maharashtra |
LUPIN PROPERTIES LIMITED |
Amalgamated
|
5.2 L | 1 | Maharashtra |
LUPIN PHARMACARE LIMITED |
Amalgamated
|
1.1 Cr | 1 | Maharashtra |
RAHAS MERCANTILE PRIVATE LIMITED |
Amalgamated
|
108.0 Cr | 1 | Maharashtra |
VISIOMED INVESTMENTS PRIVATE LIMITED |
Active
|
5.0 Cr | 1 | Maharashtra |
LUPIN ATHARV ABILITY LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
LUPIN MANUFACTURING SOLUTIONS LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
POLYNOVA INDUSTRIES LIMITED |
Active
|
23.0 Cr | 1 | Maharashtra |
LUPIN DIGITAL HEALTH LIMITED |
Active
|
62.3 Cr | 2 | Maharashtra |
LUPIN DIAGNOSTICS LIMITED |
Active
|
202.6 Cr | 2 | Maharashtra |
The incorporation date of LUPIN BIOLOGICS LIMITED is 28 January, 2021
The authorized share capital of LUPIN BIOLOGICS LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of LUPIN BIOLOGICS LIMITED is INR ₹ 15.0 L.
The registered address of LUPIN BIOLOGICS LIMITED is Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz East Mumbai Mumbai City Maharashtra - 400055
The CIN number of LUPIN BIOLOGICS LIMITED is U24299MH2021PLC354211.